iSpecimen Inc.
For the period ended Mar 31, 2025. Filed May 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Board Committees
On February 19, 2025, the Board of Directors (the “Board”) appointed Ms. Katharyn Field as President of the Company, effective immediately. In connection with her appointment, Ms. Field resigned as a member of the Board, and Ms. Siyun Yang was appointed as an independent director to fill the resulting vacancy, effective immediately.
Ms. Yang has also been appointed to serve on the Audit Committee and Nominating and Corporate Governance Committee of the Board, replacing Ms. Field. Additionally, the Board appointed Mr. Richard Paolone as Chair of the Board, replacing Ms. Field in this role. Mr. Robert Bradley Lim remains the Company’s Chief Executive Officer and a member of the Board.
The table below shows the approved composition of each standing committee of the Board of Directors:
| Committee | Chair | Members |
|---|---|---|
| Audit Committee | John L. Brooks III | John L. Brooks III, Richard Paolone, and Siyun Yang |
| Compensation Committee | Richard Paolone | Richard Paolone, Avtar Dhaliwal and John L. Brooks III |
| Nominating and Corporate Governance Committee | Avtar Dhaliwal | Avtar Dhaliwal and Siyun Yang |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.